DE69015270T2 - Cyclische vinyloge N-hydroxy-N-methylharnstoffe verwendbar als 5-Lipoygenase-Inhibitoren. - Google Patents

Cyclische vinyloge N-hydroxy-N-methylharnstoffe verwendbar als 5-Lipoygenase-Inhibitoren.

Info

Publication number
DE69015270T2
DE69015270T2 DE69015270T DE69015270T DE69015270T2 DE 69015270 T2 DE69015270 T2 DE 69015270T2 DE 69015270 T DE69015270 T DE 69015270T DE 69015270 T DE69015270 T DE 69015270T DE 69015270 T2 DE69015270 T2 DE 69015270T2
Authority
DE
Germany
Prior art keywords
methylureas
hydroxy
lipoygenase
inhibitors
usable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69015270T
Other languages
English (en)
Other versions
DE69015270D1 (de
Inventor
Gary A Flynn
Douglas W Beight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69015270D1 publication Critical patent/DE69015270D1/de
Publication of DE69015270T2 publication Critical patent/DE69015270T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE69015270T 1989-07-17 1990-07-17 Cyclische vinyloge N-hydroxy-N-methylharnstoffe verwendbar als 5-Lipoygenase-Inhibitoren. Expired - Fee Related DE69015270T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/380,937 US5026861A (en) 1989-07-17 1989-07-17 Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones

Publications (2)

Publication Number Publication Date
DE69015270D1 DE69015270D1 (de) 1995-02-02
DE69015270T2 true DE69015270T2 (de) 1995-06-08

Family

ID=23503027

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69015270T Expired - Fee Related DE69015270T2 (de) 1989-07-17 1990-07-17 Cyclische vinyloge N-hydroxy-N-methylharnstoffe verwendbar als 5-Lipoygenase-Inhibitoren.

Country Status (10)

Country Link
US (1) US5026861A (de)
EP (1) EP0409163B1 (de)
JP (1) JP2879464B2 (de)
AT (1) ATE115948T1 (de)
AU (1) AU627339B2 (de)
CA (1) CA2021340C (de)
DE (1) DE69015270T2 (de)
DK (1) DK0409163T3 (de)
ES (1) ES2068952T3 (de)
GR (1) GR3015458T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109010A (en) * 1989-07-17 1992-04-28 Merrell Dow Pharmaceuticals Inc. Dibenzofuranyl substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones
DE4213919A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4213931A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US7937897B2 (en) * 2006-01-25 2011-05-10 Yusenkaisha Japan Isusyc Dome-shaped shelter
WO2010067085A2 (en) * 2008-12-12 2010-06-17 Wista Laboratories Ltd. Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-υ-carboline and analogues and intermediates
CN103384563B (zh) 2011-02-21 2015-04-22 佳能株式会社 热处理设备及制造调色剂的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0623194B2 (ja) * 1985-03-23 1994-03-30 鐘淵化学工業株式会社 新規ラクタム誘導体及び抗炎症剤
JPS63115859A (ja) * 1986-10-31 1988-05-20 Eisai Co Ltd ２−ピロリドン誘導体を含有する抗炎症剤

Also Published As

Publication number Publication date
ATE115948T1 (de) 1995-01-15
CA2021340A1 (en) 1991-01-18
CA2021340C (en) 2001-01-23
JP2879464B2 (ja) 1999-04-05
DK0409163T3 (da) 1995-02-20
ES2068952T3 (es) 1995-05-01
GR3015458T3 (en) 1995-06-30
EP0409163B1 (de) 1994-12-21
AU5900190A (en) 1991-01-17
EP0409163A2 (de) 1991-01-23
AU627339B2 (en) 1992-08-20
EP0409163A3 (en) 1991-03-20
JPH0352858A (ja) 1991-03-07
DE69015270D1 (de) 1995-02-02
US5026861A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
DE59000652D1 (de) Verwendung von umsetzungsprodukten von alkenylspirobislactonen und aminen als paraffindispergatoren.
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
DE69111596D1 (de) Verwendung von zwitterionen zur mobilisierung isoelektrisch fokussierter ampholytzonen.
DE69026022D1 (de) Membrane hergestellt aus Copolymeren von Polyimiden und aliphatischen Polyestern .
ATE150299T1 (de) Verwendung von derivaten des 4-phenyl-1,2,3,4- tetrahydro-1-naphthalenamins zur behandlung von psychose, entzündung und als immununterdrücker
DE69030310D1 (de) Beschränkungsabhängig gesteuerte on-line Erkennung von handgeschriebenen Zeichen und Symbolen
ATE93258T1 (de) Coextrusionsfaehige klebstoffe und damit hergestellte gegenstaende.
DE58906363D1 (de) Verfahren zur Überführung von festen, weitgehend wasserfreien Abfallstoffen in Glasform sowie Vorrichtung zur Durchführung des Verfahrens.
DE69218621T2 (de) Endlosformular und vorrichtung zum herstellen von briefbogen davon
DE3888146T2 (de) Modifizierte Polytetrafluoräthylenharze und damit hergestellte Zusammensetzungen.
DE69022553T2 (de) Vorrichtung zum Unterdrücken von Spannungsschwankungen und Oberschwingungen.
IT9048221A0 (it) Procedimento e dispositivo per la adduzione di bottiglie oppure similari
DE68923131T2 (de) Bohrer, Schleifverfahren und Schleifvorrichtung.
DE69015270T2 (de) Cyclische vinyloge N-hydroxy-N-methylharnstoffe verwendbar als 5-Lipoygenase-Inhibitoren.
DE69011834T2 (de) Vorrichtung zur Erzeugung optischer Oberwellen und dieselbe benutzende Vorrichtung.
ES2135477T3 (es) Proceso de produccion de (s)-3-amino-1-pirrolidinas sustituidas.
DE69007449D1 (de) Verfahren zur Herstellung von Leistungsmos- und Halbleiteranordnungen und damit hergestellten Anordnungen.
DE69012298T2 (de) Heizen von Lagern und dergleichen.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
DE69424768D1 (de) Polydioxolanhochmolekulargewichte und herstellungsverfahren
FI893777A (fi) Fyto- och zoosteroler samt derivat daerav med foerbaettrad vattenloeslighet.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
DE69024613D1 (de) Einrichtung zur Erzeugung von Schaltkriterien und zur adaptiven Entzerrung von Datensprektren
DK604589A (da) Peptider, og analysesaet med indhold af saadanne forbindelser
DE59007354D1 (de) Monohydrochlorid und Monomethansulfonat von Amonafide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee